---  
layout: startup_page  
title: "Actio Biosciences"  
id: "actiobiosciences.com"  
permalink: "/actiobiosciencesactiobiosciences.com06182025/"  
website: "https://actiobiosciences.com/"  
funding_round: "Series B"  
funding_amount: "$66M"  
investors: "Regeneron Ventures, Deerfield Management, Canaan, Droia Ventures, Euclidean Capital"  
about: "Actio Biosciences is a clinical-stage biotechnology company developing therapeutics that target shared underlying biology in both rare and common diseases using a precision medicine strategy. They are focused on developing new therapeutics to treat rare diseases like KCNT1-related epilepsy and Charcot-Marie-Tooth disease type 2C by leveraging advances in genetics and precision medicine."  
markets: "Biotech, Therapeutics, Genetics, Pharmaceuticals, Rare Diseases"  
hq: "San Diego, California, United States"  
founded_year: "2021"  
linkedin: "https://www.linkedin.com/company/actiobio"  
twitter: "https://x.com/actiobiosci"  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/actio-biosciences"  
pitchbook: "https://pitchbook.com/profiles/company/502937-92"  

date_display: "18-Jun-2025"  
date: "2025-06-18"

# SEO Optimization  
meta_title: "Actio Biosciences - Series B Funding ($66M)"  
meta_description: "Actio Biosciences, Actio Biosciences is a clinical-stage biotechnology company developing therapeutics that target shared underlying biology in both rare and common dise..."  
meta_keywords: "Actio Biosciences, Biotech, Therapeutics, Genetics, Pharmaceuticals, Rare Diseases, Series B funding"  
canonical_url: "https://startup.projectstartups.com/actiobiosciencesactiobiosciences.com06182025/"  
---